Target intelligence / Profile preview

Beta-tubulin (β-tubulin)

Target
β-tubulin
Molecular classification
Structural protein, Cytoskeletal protein, Microtubule subunit
01

Overview

Beta-tubulin is one of the two major subunits (alongside alpha-tubulin) forming the heterodimeric building blocks of microtubules, essential cytoskeletal filaments in all eukaryotic cells. Each tubulin monomer (~50 kDa) binds a guanine nucleotide—GTP in β-tubulin is hydrolyzable and crucial for microtubule dynamics. Microtubules assemble from linear protofilaments of α/β-tubulin dimers and play key roles in maintaining cell shape, chromosome segregation during mitosis and meiosis, intracellular transport, and motility of cilia and flagella[1][5][6][8][9]. Several β-tubulin isotypes exist, encoded by different genes (e.g., β1, β2, β3, β4a, β4b, β5, β6), with some tissues expressing specific isotypes (e.g., β3 in neurons)[2][10]. Post-translational modifications and isotype switching can influence microtubule function and confer resistance to anti-microtubule cancer drugs[5][7][10]. β-tubulin is the molecular target for a variety of anticancer drugs, many of which are essential in modern chemotherapy regimens. Drug-induced interference with microtubule dynamics can lead to cell cycle arrest and apoptosis in rapidly dividing cells, but also poses risks for toxicity in non-cancer tissues, especially nerves and bone marrow[5][7]. β-tubulin is overexpressed or mutated in several cancers and is considered a central player in the development of resistance to microtubule-targeting agents[5][7][10].

Other names
Beta tubulinTUBB (gene symbol)Microtubule beta chainTUBB1, TUBB2A, TUBB3, etc. (for specific isotypes)
02

Mechanism of action

Stabilization of microtubules (e.g., by paclitaxel); Destabilization/depolymerization of microtubules (e.g., by vincristine, colchicine); Inhibition of microtubule dynamics leading to mitotic arrest and apoptosis

03

Biological functions

Cytoskeletal structureCell division (mitosis, meiosis)Intracellular transportMaintenance of cell shapeCilia and flagella motility
04

Disease associations

CancerNeurodegenerative diseases (e.g., Alzheimer’s disease)Inherited tubulinopathies (brain development disorders)Drug resistance in cancersInflammation/allergy (via mast cells)
05

Safety considerations

Neurotoxicity (due to disruption of microtubules in neurons by drugs)Myelosuppression (bone marrow toxicity)Drug resistance via changes in β-tubulin isotype or expression
06

Interacting drugs

Paclitaxel (Taxol)

7 more in the full profile.

07

Biomarkers

Tubulin isotype expression (e.g., βIII-tubulin in cancer)Tubulin mutations in certain tubulinopathies

Beyond the preview

Go deeper on Beta-tubulin (β-tubulin).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beta-tubulin (β-tubulin).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call